Bronchiolitis
Conditions
Interventions
Treatment group 2 (short period):Regular treatment plus administration of montelukast for 7 days
Control group:General regular treatment: anti-infection, oxygen uptake, cough suppression, sedation and inhalation therapy ofa2-receptor agonists ventolin
Treatment group 1:Regular treatment and inhalation therapy of budesonide
Treatment group 3 (long period):Regular treatment and inhalation therapy of Montelukast for 28 days
Sponsors
Postgraduate Department in the First Hospital Affiliated to Xinjiang Medical University
Eligibility
Sex/Gender
All
Age
5 Years to 12 Years
Inclusion criteria
Inclusion criteria: The children with mild to moderate bronchiolitis
Exclusion criteria
Exclusion criteria: 1. asthma history in past; 2. with administration of leukotriene receptor antagonists in recent 3 months; 3. combined with either following disease: respiratory failure and heart failure, asthma and asthmatoid bronchitis, congenital heart diseases, tuberculosis infection, bronchial dystrophy and foreign body of bronchus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of asthma; | — |
Secondary
| Measure | Time frame |
|---|---|
| Average length of Hospitalization, lung function, serum IgE, the incidence of asthma; | — |
Countries
China
Contacts
Public ContactPeiru Xu
Outcome results
None listed